Prange Karen
SEC-identified person · CIK 1566083 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Outset Medical, Inc. OM | Director | filed 2026–2026 |
| Atricure, Inc. atrc | Director | filed 2019–2026 |
| Embecta Corp. EMBC WI | Director | filed 2022–2026 |
| Nevro Corp NVRO | Director | filed 2019–2025 |
| Viewray, Inc. VRAY | Director | filed 2021–2023 |
| Cantel Medical Corp CMN | Director | filed 2019–2021 |
| Schein Henry INC HSIC | EVP&CEO Gl.AH.Med.Den.Sur.Grp | filed 2016–2018 |
| Boston Scientific Corp bsx | SVP&Pres, Uro & Women's Health | filed 2013–2016 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.